- •InterLACE is an international collaboration of 20 observational studies across 10 countries.
- •Harmonized individual-level data on reproductive health and chronic disease are available from 230,000 women.
- •The prevalence of diabetes and cardiovascular disease among mid-aged women were 5% and 7% at the end of study follow-up, respectively.
- •InterLACE enables a detailed review of methodologies currently used in the field of women’s health.
The International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events (InterLACE) project is a global research collaboration that aims to advance understanding of women’s reproductive health in relation to chronic disease risk by pooling individual participant data from several cohort and cross-sectional studies. The aim of this paper is to describe the characteristics of contributing studies and to present the distribution of demographic and reproductive factors and chronic disease outcomes in InterLACE.
InterLACE is an individual-level pooled study of 20 observational studies (12 of which are longitudinal) from ten countries. Variables were harmonized across studies to create a new and systematic synthesis of life-course data.
Main outcome measures
Harmonized data were derived in three domains: 1) socio-demographic and lifestyle factors, 2) female reproductive characteristics, and 3) chronic disease outcomes (cardiovascular disease (CVD) and diabetes).
InterLACE pooled data from 229,054 mid-aged women. Overall, 76% of the women were Caucasian and 22% Japanese; other ethnicities (of 300 or more participants) included Hispanic/Latin American (0.2%), Chinese (0.2%), Middle Eastern (0.3%), African/black (0.5%), and Other (1.0%). The median age at baseline was 47 years (Inter-quartile range (IQR): 41–53), and that at the last follow-up was 56 years (IQR: 48–64). Regarding reproductive characteristics, half of the women (49.8%) had their first menstruation (menarche) at 12–13 years of age. The distribution of menopausal status and the prevalence of chronic disease varied considerably among studies. At baseline, most women (57%) were pre- or peri-menopausal, 20% reported a natural menopause (range 0.8–55.6%) and the remainder had surgery or were taking hormones. By the end of follow-up, the prevalence rates of CVD and diabetes were 7.2% (range 0.9–24.6%) and 5.1% (range 1.3–13.2%), respectively.
The scale and heterogeneity of InterLACE data provide an opportunity to strengthen evidence concerning the relationships between reproductive health through life and subsequent risks of chronic disease, including cross-cultural comparisons.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Maturitas
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.BMJ. 2006; 332: 73-78
- Hot flashes and subclinical cardiovascular disease: findings from the study of women’s health across the nation heart study.Circulation. 2008; 118: 1234-1240
- Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis.Menopause. 2012; 19: 1081-1087
- Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women.Cancer Causes Control. 2006; 17: 949-955
- Systematic review and meta-analysis of age at menarche and risk of type 2 diabetes.Acta Diabetol. 2014; 51: 519-528
- Age at menarche and risks of all-cause and cardiovascular death: a systematic review and meta-analysis.Am. J. Epidemiol. 2014; 180: 29-40
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.Lancet Oncol. 2012; 13: 1141-1151
- Early life circumstances and their impact on menarche and menopause.Womens Health. 2009; 5: 175-190
- Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged women.J. Bone Miner. Res. 2009; 24: 144-152
- Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study.Int. J. Epidemiol. 2016; (Epub ahead of print)
- Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study.Diabetes Care. 2013; 36: 1012-1019
- Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.Menopause. 2006; 13: 265-279
- Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status.Climacteric. 2006; 9: 40-48
- Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.BJOG. 2005; 112: 476-485
- Smoking body mass index, socioeconomic status and the menopausal transition in a British national cohort.Int. J. Epidemiol. 2000; 29: 845-851
- Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants.Maturitas. 2011; 70: 110-119
- Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.Am. J. Public Health. 2006; 96: 1226-1235
- InterLACE: a new international collaboration for a life course approach to women’s reproductive health and chronic disease events.Maturitas. 2013; 74: 235-240
- A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives.Int. J. Epidemiol. 2002; 31: 285-293
- A life course approach to reproductive health: theory and methods.Maturitas. 2010; 65: 92-97
- Reproductive health as a sentinel of chronic disease in women.Womens Health. 2009; 5: 101-105
- Why Should We Consider a Life Course Approach to Women’s Health Care? Scientific Impact Paper No. 27.Royal College of Obstetricians and Gynaecologists, 2011
- Cohort profile update: Australian longitudinal study on women’s health.Int. J. Epidemiol. 2015; 4 (1547a-1547f)
- Menopause in Australia and Japan: effects of country of residence on menopausal status and menopausal symptoms.Climacteric. 2004; 7: 165-174
- The Melbourne Collaborative Cohort Study.International Agency for Research on Cancer, Lyon2002
- Cohort profile: the Danish nurse cohort.Int. J. Epidemiol. 2012; 41: 1241-1247
- Cohort profile: the Swedish women’s lifestyle and health cohort.Int. J. Epidemiol. 2015; (Epub ahead of print)
- Cohort profile: the 1946 national birth cohort (MRC national survey of health and development).Int. J. Epidemiol. 2006; 35: 49-54
- Cohort profile: 1958 British birth cohort (national child development study).Int. J. Epidemiol. 2006; 35: 34-41
- Cohort profile: the English longitudinal study of ageing.Int. J. Epidemiol. 2013; 42: 1640-1648
- Cohort profile: the UK women’s cohort study (UKWCS).Int. J. Epidemiol. 2015; (Epub ahead of print)
- Cohort profile: the Whitehall II study.Int. J. Epidemiol. 2005; 34: 251-256
- SWAN: a Multi-Center, Multiethnic Community-Based Cohort Study of Women and The Menopausal Transition.Academic Press, San Diego2000
- Cognitive symptoms during the menopausal transition and early postmenopause.Climacteric. 2011; 14: 252-261
- Design of the Japan Nurses’ Health Study: a prospective occupational cohort study of women’s health in Japan.Ind. Health. 2007; 45: 679-686
- Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii.Menopause. 2007; 14: 261-269
- Recruitment and retention of healthy minority women into community-based longitudinal research.J. Womens Health Gend. Based Med. 2001; 10: 77-85
- Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts.Menopause. 2004; 11: 456-465
- Symptom reporting around the menopause in Beirut, Lebanon.Maturitas. 1999; 33: 249-258
- The menopause in Spain: results of the DAMES (Decisions At MEnopause) study.Maturitas. 2005; 52: 190-198
- Menopause in Morocco: symptomatology and medical management.Maturitas. 2002; 41: 87-95
- Ethnicity, language and populations.in: Mateos P. Names, Ethnicity and Populations. Springer, Verlag Berlin Heidelberg2014: 9-27
- From menarche to menopause: trends among US women born from 1912 to 1969.Am. J. Epidemiol. 2006; 164: 1003-1011
- Evidence for a secular trend in age of menarche.New Engl. J. Med. 1982; 306: 1033-1035
- Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diab. Care. 2004; 27: 1047-1053
- Global burden of obesity in 2005 and projections to 2030.Int. J. Obes. (Lond). 2008; 32: 1431-1437
- Global Status Report on Noncommunicable Diseases: Attaining The Nine Global Noncommunicable Diseases Targets; A Shared Responsibility.World Health Organization, 2014
Published online: August 04, 2016
Accepted: July 28, 2016
Received in revised form: July 28, 2016
Received: June 30, 2016
© 2016 Elsevier Ireland Ltd. All rights reserved.